Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HLA-DRA antibody

This Mouse Monoclonal antibody specifically detects HLA-DRA in FACS and IF. It exhibits reactivity toward Human and Monkey.
Catalog No. ABIN6939635
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for HLA-DRA antibody (ABIN6939635)

Target

See all HLA-DRA Antibodies
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reactivity

  • 151
  • 17
  • 11
  • 10
  • 9
  • 9
  • 4
  • 3
  • 3
  • 1
Human, Monkey

Host

  • 88
  • 77
  • 4
  • 1
  • 1
Mouse

Clonality

  • 101
  • 70
Monoclonal

Conjugate

  • 91
  • 13
  • 9
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HLA-DRA antibody is un-conjugated

Application

  • 80
  • 67
  • 53
  • 52
  • 25
  • 21
  • 13
  • 9
  • 9
  • 5
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF)

Clone

IPO-10
  • Purpose

    HLA-DRA (MHC II) Antibody

    Specificity

    MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected. '

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Spleen cells of a patient with hairy cell leukemia (Daudi cells)

    Isotype

    IgG3, kappa
  • Application Notes

    Positive Control: Ramos, Daudi or HuT78 cells. Tonsil or lymph node.

    Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Alternative Name

    HLA-DRA

    Background

    DR alpha chain, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen DR alpha chain, HLA DRA, HLA DRA1, HLA-DRA, HLADRA1, Major histocompatibility complex class II DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA

    Daudi or HuT78 cells. Tonsil or lymph node., Ramos

    Molecular Weight

    36kDa

    Gene ID

    3122, 520048

    UniProt

    P01903

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
You are here:
Chat with us!